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Mycobacterium bovis is the cause of tuberculosis (TB) in a wide range of species, 
including white rhinoceroses (Ceratotherium simum). Control of the disease relies on the 
indirect detection of infection by measuring pathogen-specific responses of the host. 
These are poorly described in the white rhinoceros and this study aimed to characterize 
the kinetics of immune responses to M. bovis infection in this species. Three white rhi-
noceroses were infected with M. bovis and their immune sensitization to this pathogen 
was measured monthly for 20 months. Cell-mediated immunity was characterized in 
whole blood samples as the differential release of interferon-gamma in response to 
bovine purified protein derivative (PPDb) and avian PPD (PPDa) as well as the release of 
this cytokine in response to the M. bovis proteins 6 kDa early secretory antigenic target 
(ESAT-6)/10 kDa culture filtrate protein (CFP-10). Humoral immunity was quantified as 
the occurrence or the magnitude of antibody responses to the proteins ESAT-6/CFP-10, 
MPB83, MPB83/MPB70, and PPDb. The magnitude and duration of immune reactivity 
varied between individuals; however, peak responses to these antigens were detected 
in all animals circa 5–9 months postinfection. Hereafter, they gradually declined to low 
or undetectable levels. This pattern was associated with limited TB-like pathology at 
postmortem examination and appeared to reflect the control of M. bovis infection follow-
ing the development of the adaptive immune response. Measurement of these markers 
could prove useful for assessing the disease status or treatment of naturally infected 
animals. Moreover, immune responses identified in this study might be used to detect 
infection; however, further studies are required to confirm their diagnostic utility.
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inTrODUcTiOn
White rhinoceroses (Ceratotherium simum) are classified as 
“Near Threatened” by the International Union for Conservation 
of Nature, with the majority of animals occurring in South 
Africa (1). Of these, a substantial number occur in the greater 
Kruger National Park (KNP) and the Hluhluwe-iMfolozi Park 
(HiP). However, because of their economic value and threat-
ened conservation status, animals from these populations are 
regularly translocated to other reserves and privately owned 
collections. Importantly, movement of animals from these 
areas could present a risk of translocating Mycobacterium 
bovis, a major cause of tuberculosis (TB). This pathogen can 
infect a wide variety of domestic and wildlife hosts, including 
rhinoceros species (2) and has become established in both the 
KNP and HiP (3). The recent detection, in the KNP, of a case of 
severe pulmonary TB in a black rhinoceros (4) and confirmed 
M. bovis granulomas in lymph nodes of four white rhinoceroses 
(unpublished data) highlights the potential risk of movement 
of these species.
Tuberculosis is slowly progressive and the causative organ-
isms may initially be contained within well circumscribed 
granulomas (5). For this reason, detection of the pathogen can 
be challenging and, as in other species, TB in rhinoceroses might 
only be diagnosed postmortem or once animals have developed 
advanced disease (2). Infection is therefore often diagnosed indi-
rectly by measuring the host’s adaptive immune response toward 
M. bovis antigens. This is commonly done by quantifying either 
the in vivo or the in vitro immune response to purified protein 
derivative (PPD), a preparation containing a broad range of 
M. bovis antigens (6, 7). Alternatively, recombinant proteins that 
are more specific to M. bovis can be utilized as test antigens and 
these include 6  kDa early secretory antigenic target (ESAT-6), 
10  kDa culture filtrate protein (CFP-10), MPB70, and MPB83 
(8). Assessment of immune responses to these and other antigens 
might also be used to distinguish between latent infection and 
progressive disease or to monitor treatment in both humans and 
animals (8, 9).
The present study forms part of a broader project that 
characterized the clinical features and associated gross and 
histopathology of the experimental infection of three white 
rhinoceroses with M. bovis (10). In all cases, 20 months after 
infection, animals had shown no clinical signs of TB disease 
and had limited TB-like pathology (10). We hypothesized that 
quantifying the adaptive immune responses to M. bovis in these 
animals would provide an indirect measure of their infection 
and disease status. As such, we aimed to characterize (i) their 
immune sensitization to selected antigens following infection 




The capture, maintenance, chemical immobilization, infection, 
and sampling of animals in the KNP, as well as biohazard contain-
ment, have previously been described in detail (10). Briefly, three 
subadult male white rhinoceroses, identified as PB1, PB2, and 
PB4, were infected by endoscopic endobronchial instillation of 
the M. bovis strain SB0121, a genotype commonly isolated from 
wildlife in the KNP. The inocula for the three animals contained 
approximately 2.1 ×  103 colony forming units (cfu), 1.8 ×  102 
and 1.4 × 103 cfu, respectively. Each month, from 3 months prior 
to infection until 20  months postinfection (PI), animals were 
chemically immobilized and blood was collected from the radial 
vein into lithium heparin and serum vacutainer tubes (Fisher 
Scientific, Suwanee, GA, USA) and used in the immunological 
assays described below (Table 1). On these occasions, endoscopic 
bronchoalveolar lavages were performed for mycobacterial cul-
ture. Twenty months after infection, animals were euthanized, 
postmortem examinations performed, and systematic tissue 
sampling conducted to determine the presence or absence of 
M. bovis by histopathology, mycobacterial culture, and polymerase 
chain reaction (PCR) and findings have been previously reported 
in detail (10). Approval for the study was obtained from the 
Animal Ethics Committees of the South African National Parks 
and Stellenbosch University (proposal SU-ACUM12-00012) 
as well the South African National Department of Agriculture, 
Forestry and Fisheries in terms of Section 20 of the Animal 
Diseases Act (Permit 12/11/1/1/6/1).
rhinoceros-specific interferon-gamma 
(iFn-γ) release assay
Blood collected in heparin tubes was processed within 12  h 
after collection as previously described (11). Briefly, whole 
blood samples were incubated at 37°C in 5% CO2 for 24 h with 
M. bovis PPD (PPDb, 20  µg/ml) and M. avium PPD (PPDa, 
20  µg/ml), PMA/CaI (0.1/2  μg/ml—positive control), culture 
medium (Nil—negative control), respectively. Plasma was har-
vested following centrifugation at 1,088 × g for 5 min and stored at 
−80°C until tested, in duplicate, in the rhinoceros-specific IFN-γ 
capture enzyme-linked immunoassay (ELISA) (11). The results of 
the ELISA were determined at 490 nm using an ELISA plate reader 
(BioTek, Powerwave XS2, Gen5 software). An initial reference/
blank reading was performed on the plate prior to the blocking 
step, at the same wavelength, and final optical density (OD) values 
were determined by subtracting the mean reference value from 
the mean test value for each sample well. Antigen- and mitogen-
specific release of IFN-γ was calculated as the OD value derived 
from the PPD- and PMA/CaI-stimulated samples minus that 
derived from the Nil sample. M. bovis-specific release of IFN-γ was 
calculated as the PPDb value minus the PPDa value (ΔPPDb-a).
Modified QuantiFerOn TB gold  
(in-Tube) (QFT) assay
One milliliter of heparinized whole blood was transferred to a 
“Nil” tube (containing saline) and a “TB Antigen” tube (coated 
Abbreviations: CFP-10, 10  kDa culture filtrate protein; ELISA, enzyme-linked 
immunoassay; ESAT-6, 6  kDa early secretory antigenic target; HiP, Hluhluwe-
iMfolozi Park; IFN-γ, interferon-gamma; KNP, Kruger National Park; OD, optical 
density; PBS, phosphate-buffered saline; PI, postinfection; PPDa, avian purified 
protein derivative; PPDb, bovine purified protein derivative; QFT, modified 
QuantiFERON TB Gold (In-Tube) assay; TMB, 3, 3′, 5, 5′- tetramethylbenzidine.
TaBle 1 | Immunoassays utilized to measure immune sensitization to selected antigens in Mycobacterium bovis-infected white rhinoceroses.
assay supplier Test antigens assay format reference
Rhinoceros-specific assay In-house assay M. bovis PPD; M. avium PPD IGRA (11)
Modified QFT assay Components supplied by Qiagen and Mabtech ESAT-6, CFP-10, TB 7.7 IGRA N/A
PPD ELISA In-house assay M. bovis PPD ELISA N/A
ElephantTB STAT-PAK® assay Chembio Diagnostic Systems ESAT-6/CFP-10/MPB83 LFD (8, 12)
Dual Path Platform (DPP)® VetTB assay Chembio Diagnostic Systems MPB83; ESAT-6/CFP-10 LFD (12)
Bovid DPP assay Chembio Diagnostic Systems MPB83/MPB70 LFD N/A
PPD, purified protein derivative; IGRA, interferon-gamma release assay; QFT, QuantiFERON TB Gold (In Tube); N/A, not applicable; ELISA, enzyme-linked immunosorbent assay; 
LFD, lateral flow device.
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with peptides simulating ESAT-6, CFP-10, and TB 7.7) of the QFT 
system (Qiagen, Hilden, Germany). In addition, as a measure of 
cell viability, 1 ml blood was incubated with phytohemagglutinin 
(PHA) (Sigma-Aldrich, St. Louis, MO, USA) in phosphate-
buffered saline (PBS) at a final concentration of 10 µg/ml. The 
tubes were shaken according to the manufacturer’s instructions 
and incubated for 20–24  h at 37°C. Hereafter, the tubes were 
centrifuged at 1,600 × g for 10 min and plasma was harvested and 
stored at −80°C. Plasma samples were assayed in duplicate using 
a commercial bovine IFN-γ ELISA cross-reactive with IFN-γ of 
sheep and horses (Kit 3115-1H-20; Mabtech AB, Nacka Strand, 
Sweden) that has previously been shown to detect recombinant 
rhinoceros IFN-γ (data not shown). Reactions were visualized 
using 3,3′,5,5′-tetramethylbenzidine (TMB) (BD Biosciences, 
NJ, USA) as a color substrate. The IFN-γ concentration in each 
sample was measured as the OD of each well, at a wavelength of 
450 nm, using a Labtech LT-4000 microplate reader (Lasec, Cape 
Town, South Africa). The M. bovis-specific release of IFN-γ was 
calculated as the mean OD derived for plasma harvested from the 
TB Ag tube minus the mean OD derived for plasma harvested 
from the Nil tube.
PPD elisa
Flat-bottomed 96-well microtiter plates (Nunc, New York, NY, 
USA) were coated with 100  µl of a 10  µg/ml PPDb solution 
(Prionics, Schlieren-Zurich, Switzerland) in 0.05 M carbonate-
bicarbonate buffer (pH 9.6) and incubated overnight at 4°C. For 
each well coated with antigen, a corresponding control well was 
coated with 100 µl blocking buffer (BB) consisting of 5% milk 
powder (Clover, Roodepoort, South Africa) in PBS +  0.05% 
Tween-20 (Sigma-Aldrich, St. Louis, MO, USA). After incu-
bation, plates were decanted and washed five times with PBS 
containing 0.05% Tween-20, then blocked with 200 μl/well of 
BB for 1 h at room temperature (RT). The plates were washed 
as above and serum samples diluted 1:200 in BB were added to 
duplicate wells (100 μl/well). Plates were incubated at RT for 1 h 
and then washed five times as above. Plates were then incubated 
with 100 μl/well of peroxidase-conjugated recombinant protein 
A/G (Thermo Scientific, MA, USA) diluted 1:100,000 in PBS, 
for 1 h at RT. Plates were washed as above before addition of 
100  μl/well of TMB and subsequently incubated in the dark 
for 15 min. The reaction was stopped using 50 μl/well of 2 M 
H2SO4 and the OD of each well was measured at 450 nm using 
a LT-4000 Microplate Reader (Lasec). For each animal, an 
assay result was calculated as the mean OD value derived from 
duplicate PPD-coated wells minus that of duplicate BB-coated 
wells.
elephantTB sTaT-PaK® assay
Rhinoceros sera were tested using the ElephantTB STAT-PAK® 
assay (Chembio Diagnostic Systems, Inc., Medford, NY, USA). 
The assay has been optimized for the detection of M. tuberculosis 
infection in elephants but is not specific for a particular host spe-
cies and has previously been found useful in measuring antibody 
responses in a black rhinoceros infected with M. tuberculosis 
(12). Briefly, 30 µl of serum was added to the sample well fol-
lowed by three drops of diluent/antibody detection conjugate. If 
the sample contained antibodies to M. bovis antigens (ESAT-6/
CFP-10/MPB83), a positive line appeared as a blue band. Any 
visible band observed in the test line area by two independent 
observers and read at 20  min was considered as an antibody 
positive result.
Dual Path Platform (DPP)® VetTB  
and Bovid DPP assays
The DPP® VetTB and Bovid DPP assays (Chembio Diagnostic 
Systems, Inc.) were performed according to the manufacturer’s 
instructions as previously described (12). After 15  min, the 
test results were read. A DPP optical reader device (Chembio 
Diagnostic Systems, Inc.) was used to measure the reflectance 
of test strips and a result was quantified as a numerical score, 
represented as reflectance units (RU). The DPP® VetTB assay 
includes two test lines containing the antigens MPB83 and 
ESAT-6/CFP-10, along with a positive control. In the Bovid DPP 




The release of IFN-γ in unstimulated blood was negligible, result-
ing in median ELISA OD values of 0.08, 0.05, and 0.07 for PB1, 
PB2, and PB4, respectively. All animals displayed strong IFN-γ 
responses to PMA/CaI stimulation, with mean mitogen-specific 
OD values of 0.86, 0.83, and 0.86, respectively. The kinetics of 
PPDa and PPDb-specific IFN-γ release in whole blood from these 
animals are illustrated in Figure  1A. Immune sensitization to 
these antigens was negligible prior to infection and first observed 
at 2–3 months PI. The release of IFN-γ in response to both antigens 
was greatest between 4 and 10 months PI and the M. bovis-specific 
FigUre 1 | The kinetics of the cell-mediated immune response to Mycobacterium bovis infection in the white rhinoceros. Following M. bovis infection, whole 
blood from three animals (PB1, PB2, and PB4) was incubated overnight at 37°C without stimulation, or stimulation with bovine PPD purified protein derivative 
(PPDb), avian PPD (PPDa), and 6 kDa early secretory antigenic target (ESAT-6)/10 kDa culture filtrate protein (CFP-10)/TB7.7 peptides, respectively. Plasma 
interferon-gamma (IFN-γ) was measured by enzyme-linked immunoassay, in duplicate, as the optical density (OD), and antigen-specific release calculated as 
the OD derived for the unstimulated sample subtracted from that derived for each antigen (mean ΔOD ± SD). (a) Antigen-specific IFN-γ release in response 
to PPDb and PPDa, and the differential response to these antigens (ΔPPDb-a); (B) Antigen-specific IFN-γ release in response to ESAT-6/CFP-10/TB7.7 
peptides.
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PPD responses (ΔPPDb-a) peaked at circa 5–6 months PI in PB1 
and PB2 and at 11 months PI in PB4. Subsequently, IFN-γ release 
in responses to both PPDa and PPDb were low until 20 months 
PI when all animals again showed substantial responses to these 
antigens. At this time, IFN-γ release was notably greater in 
response to PPDa than PPDb in PB2 and PB4, while in PB1, the 
PPDb response was higher than that to PPDa.
Modified QFT assay
The release of IFN-γ in unstimulated blood was negligible, result-
ing in median ELISA OD values of 0.09, 0.08, and 0.09 for PB1, 
PB2, and PB3, respectively. As a result of experimental error, 
measurements of PHA-induced IFN-γ responses were available 
for only 14/21 sampling occasions for each animal. On these 
occasions, median mitogen-specific OD values were 0.81, 0.35, 
and 0.89, respectively. The kinetics of ESAT-6/CFP-10/TB7.7-
specific IFN-γ release in whole blood from PB1, PB2, and PB4 
are illustrated in Figure  1B. These antigen-specific responses 
were first observed at 1  month PI in PB2 and at 2  months PI 
in PB1 and PB4. Following infection, peak responses occurred 
at circa 6–9  months PI, after which IFN-γ release decreased 
gradually over time. At 20 months PI, PB2 displayed a moderate 
but distinct increase in IFN-γ release in response to ESAT-6/
CFP-10/TB7.7.
PPD elisa, elephantTB sTaT-PaK®,  
and DPP assays
The kinetics of the humoral responses to M. bovis antigens in PB1, 
PB2, and PB4 are illustrated in Figure 2. Using the ElephantTB 
STAT-PAK® assay, PB1 displayed humoral sensitization to the 
combined antigens ESAT-6/CFP-10/MPB83 at all time points 
from 1 to 10 months PI (Figure 2A). In contrast, antibodies to 
this antigen pool were not detected in PB2 for the duration of 
the study and only on a single occasion in PB4, i.e., 2  months 
PI (Figure  2A). Using the DPP assays, only PB1 displayed a 
strong and sustained humoral response to the M. bovis antigens 
ESAT-6/CFP-10, MPB83, and MPB83/MPB70, with sensitization 
to all three antigens detected at 5 and 6 months PI. Hereafter, the 
humoral response to MBP83 alone was not again detected in this 
animal; however, responses to MBP83/MPB70 were sustained 
until 10  months PI and responses to ESAT-6/CFP-10 peaked 
again at 14  months PI. Both PB2 and PB4 displayed very low 
antibody quantities specific for these antigens, with PB4 showing 
only a moderate response to MPB83/MPB70 at 17 months PI.
Prior to infection, levels of circulating antibodies to PPDb 
(Figure 2B) were similar in all animals, with levels rising from 2 
to 4 months PI. A peak in the PPDb-specific humoral response 
occurred circa 6 months PI, after which this gradually decreased 
in all animals.
FigUre 2 | The kinetics of the humoral response to Mycobacterium bovis infection in the white rhinoceros. Following M. bovis infection, serum antibodies of  
three animals (PB1, PB2, and PB4) were measured using selected commercial assays and an in-house bovine purified protein derivative (PPDb) enzyme-linked 
immunoassay (ELISA). (a) Serological responses to MPB83 and 6 kDa early secretory antigenic target (ESAT-6)/10 kDa culture filtrate protein (CFP-10) (Dual  
Path Platform (DPP)® VetTB assay) and MPB83/70 (Bovid DPP assay); seroreactivity to ESAT-6/CFP-10/MPB83 (ElephantTB STAT-PAK® assay) is indicated (*).  
(B) Serological responses to PPDb, measured in duplicate by indirect ELISA, and calculated as the difference in optical density (OD) between control wells and 
PPDb-coated wells (mean ΔOD ± SD).
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DiscUssiOn
Following experimental endobronchial instillation of M. bovis in 
3 white rhinoceroses, these developed time-dependent humoral 
and cell-mediated immune responses toward the antigens PPDa, 
PPDb, ESAT-6/CFP-10, MPB83, MPB83/MPB70, and ESAT-6/
CFP-10/MPB83. Notably, cell-mediated responses toward 
ESAT-6/CFP-10 and PPD showed greater consistency between 
individuals than did humoral responses toward MPB83, MPB83/
MPB70, and ESAT-6/CFP-10/MPB83. While the specific patterns 
of immune reactivity varied between individuals, peak responses 
were detected in all three animals circa 5–9  months PI, after 
which they gradually declined to low or undetectable levels.
In mice, the onset of adaptive immunity toward M. tuberculosis 
requires the active replication of the pathogen in lymph nodes 
draining the site of infection (13). Moreover, the progression 
and magnitude of this response is associated with the amount 
of antigen produced in these lymph nodes (13, 14). Similarly, 
M. bovis infection in cattle and deer invariably results in the 
development of granulomatous disease in lymph nodes draining 
the site of infection, suggesting that these tissues are the primary 
site of antigen presentation and immune activation (15). In the 
present study, during the first 5–9 months PI, the rhinoceroses 
displayed a consistent rise in immune reactivity toward M. bovis 
antigens, strongly suggesting the establishment of this infection 
in all three animals.
The magnitude and duration of M. bovis-specific immune 
reactivity appeared to reflect the disease status of each animal. 
PB1, which displayed the most robust and sustained responses to 
all test antigens was the only animal from which viable M. bovis 
was isolated, i.e., from a bronchoalveolar lavage sample collected 
5  months following infection (10). Moreover, at postmortem 
examination of PB1, acid fast bacterial rods and M. bovis DNA 
were detected in tracheobronchial and lung lesions, respectively 
(10). In contrast, PB4 displayed substantially lower responses of 
both humoral and cell-mediated immunity (CMI) and no defini-
tive confirmation of M. bovis infection was made in this animal 
by culture, histopathology, or PCR (10).
Following an initial peak circa 5–9 months PI, all rhinoceroses 
displayed a gradual decline in the magnitude of their immune 
responses, and antigen-induced IFN-γ release reached low levels 
within 12–16 months after infection. In cattle, the severity of TB 
disease correlates with both the magnitude of ESAT-6-specific 
CMI (5) and the humoral response to M. bovis (6). Similarly, in 
rabbits experimentally infected with M. tuberculosis, progres-
sive disease is associated with strongly rising titers of anti-PPD 
antibodies (16), while control of the infection is characterized by 
low seroreactivity to PPD that declines over time (17). A similar 
pattern of waning sensitization to ESAT-6/CFP-10 has been 
documented in naturally infected black rhinoceroses during 
treatment for M. tuberculosis infection (8). Such patterns are 
associated with a decrease in pathogen burden and antigenic 
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load (17). Notably, for PB1, the peak in CMI responses at 
5 months PI occurred at the only time point that viable M. bovis 
was isolated from the respiratory tract. Hereafter, the gradual 
decline in M. bovis-specific immune responses, as for the other 
two experimentally infected animals, was associated with lim-
ited TB-like pathology at postmortem examination and a failure 
to isolate viable organisms from multiple tissues. Together, 
these immune response patterns appear to reflect the control of 
M. bovis infection in these animals following the development 
of the adaptive immune response.
Humoral responses broadly mirrored those of CMI, with PB1 
showing strong seroreactivity to all test antigens. However, PB2 
and PB4 showed limited detectable sensitization to the M. bovis-
specific antigens MPB83, MPB83/MPB70, and ESAT-6/CFP-10. 
Similar differences in seroreactivity of individual animals are seen 
following experimental infection in other species, including cat-
tle and badgers (18, 19). As for these hosts, this phenomenon in 
rhinoceroses could be related to the infection dose administered 
to each animal or reflect a natural animal-to-animal diversity in 
antigen recognition (18, 19). Nonetheless, following infection, 
PB2 and PB4 did display a transient elevation in seroreactivity 
to PPDb. In part, this may reflect the far greater range of anti-
genic epitopes present in PPDb compared to the more specific 
antigens such as MPB83 and ESAT-6. Alternatively, because PPD 
includes antigens that are shared between various mycobacterial 
species (20), the detection of immunological sensitization to 
PPDb might in part reflect the boosting of immune responses 
to cross-reactive antigens. Evidence of such cross-reactivity is 
indicated by the distinct CMI response of PB1 to PPDa following 
M. bovis infection.
At 20 months PI, all rhinoceroses displayed a rapid increase 
in IFN-γ release in response to the antigens PPDb, PPDa, and 
ESAT-6/CFP-10/TB7.7. This boosting of the immune response 
might have reflected acute progression of TB disease in these 
animals (5); however, this is unlikely given the paucity of M. bovis- 
associated pathology at postmortem examination shortly after 
this sampling time point (10). Alternatively, this observation may 
be related to viral pneumonia observed in PB2 and PB4 (10). 
The immune response associated with acute viral infections can 
induce non-specific “bystander” activation and proliferation of 
lymphocytes (21), giving rise to IFN-γ production (22). Notably, 
at this time, PB2 and PB4 displayed a greater response to PPDa 
than to PPDb. This may be further evidence that this phenom-
enon resulted from a non-specific mycobacterial or viral infection 
rather than an M. bovis-specific event.
Results from the present study provide insight into the tem-
poral patterns of immunological responses to M. bovis infection 
in white rhinoceroses. However, limitations in the study design 
must be considered when extrapolating findings to animals under 
natural conditions. First, the nature of the study precluded statis-
tical analysis of data, partly because of the limited sample size and 
partly because of the substantial variation in immune responses 
between individuals. Unlike studies using inbred species such as 
experimental mice (13), this limitation is commonly experienced 
in studies investigating outbred animals, especially wildlife (19). 
Second, differences in the infective doses administered to each 
animal may have accounted for the differences in pathological 
outcomes and immune response profiles and these may not 
reflect natural infection. Nonetheless, it is notable that while 
the magnitude of these responses differed between individuals, 
their kinetics were comparable. Lastly, the three experimentally 
infected individuals were all relatively young, had been treated 
for ectoparasites, were generally free from severe stressors and 
were well fed (10). As such, the immunological profiles described 
in this study may reflect an optimal outcome of infection and 
not necessarily a scenario in which these and other factors might 
affect either disease progression or resolution.
In summary, this study has characterized antigen-specific 
immune response patterns of white rhinoceroses that appear 
to reflect the effective control of M. bovis infection by this host. 
Importantly, the measurement of these responses might prove 
useful for assessing the disease status or response to treatment 
of naturally infected animals. Moreover, the immunological 
markers identified in this study might be used for the detection 
of infection; however, further studies investigating these markers 
in M. bovis-uninfected animals are required to confirm their 
diagnostic utility.
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